Home > News

News

Unwired Planet International Ltd v (1) Huawei Technologies Co. Ltd (2) Huawei Technologies (UK) Co. Ltd5 April 2017Adrian Speck QC, Isabel Jamal and Tom Jones appeared for the Claimant, Unwired Planet, and Andrew Lykiardopoulos QC appeared for the Defendant, Huawei, in a landmark action concerning the nature of a patent holder’s obligations to license Standard Essential Patents (SEPs) on Fair, Reasonable and Non-Discriminatory (FRAND) terms. In a much-anticipated judgment, Birss J found […]
Congratulations to our Door Tenant Eleonora Rosati on her promotion4 April 20178 New Square congratulate Eleonora Rosati on her promotion to Associate Professor in Intellectual Property Law at the University of Southampton.
Teva UK Ltd v Merck Sharp & Dohme Corp [2017] EWHC 539 (Pat)21 March 2017Charlotte May QC and Lindsay Lane represented the first claimant (“Teva”) in its successful challenge of the defendant’s (“Merck”) supplementary protection certificate (SPC) for an anti-viral drug marketed as Atripla. The SPC covered a combination of the active ingredient efavirenz together with emtricitabine and tenofovir. The Court agreed with Teva’s case that the SPC failed […]
Synthon B.V. v Teva Pharmaceutical Industries Limited [2017] EWCA Civ 14821 March 2017Andrew Lykiardopoulos QC represented the Appellant, “Synthon” in its appeal concerning Teva’s patent for glatiramer acetate (marketed as “Copaxone”). The Patent related to a method of making glatiramer acetate with limited levels bromine and free metal impurities. Synthon had challenged the validity of the patent on grounds of lack of novelty, obviousness and insufficiency. At […]
8 New Square awarded UK IP Set of the year at the MIP awards dinner10 March 2017For the second year running, 8 New Square were awarded the UK IP Set of the year by the Managing Intellectual Property Global publication at an awards dinner in the Savoy Hotel in London on 9th March. James Abrahams QC accompanied by Martin Williams collected the award.